Oronia MSM Joint Recovery
Natural health product licensed in Canada
- Other names
- MSM Joint Recovery, Oronia Joint Recovery, Oronia MSM
- Licence holder
- TNC Ltd.
- NPN or DIN-HM
- 80082607
- Status
- Active licence
- Licence date
- 23 January 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Méthylsulfonylméthane Source : Sulfone de diméthyl | 500 milligramme | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Glucosamine sulfate | 100 milligramme | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Exosquelette de crevette | 100 milligramme | Not calculated |
| Boswellia serrata Source : Stem bark oleogum resin | 150 milligramme | Not calculated |
| Acide hyaluronique Source : Gallus gallus - Crête | 40 milligramme | Not calculated |
| Acide hyaluronique Source : Acide hyaluronique | 40 milligramme | Not calculated |
Non-medicinal ingredients
Pullulane, Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Helps to relieve joint pain and swelling associated with osteoarthritis of the knee. Helps to relieve joint pain associated with osteoarthritis (of the knee). Helps support joint health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If symptoms worsen, consult a health care practitioner.
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use. Some people may experience mild gastrointestinal disturbances such as diarrhoea, abdominal pain, heartburn, nausea and vomiting; in which case, discontinue use.
- Contre-indications
If you are pregnant or breastfeeding, do not use this product. If you are allergic to acetylsalicylic acid (ASA) or other salicylates, do not use this product.
Source
Official Health Canada record, licence 80082607
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.